Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients.

BACKGROUND/AIMS It remains controversial whether Helicobacter pylori infection causes symptoms in non-ulcer dyspepsia. One hundred non-ulcer dyspepsia patients were screened for H. pylori infection between November 1989 and February 1994. Forty patients entered a trial where both infected and uninfected patients were treated with H. pylori therapy, with the uninfected group serving as controls. METHODS Non-ulcer dyspepsia was defined as unexplained epigastric discomfort lasting for at least 4 wk. From November 1989 until February 1992, all patients, regardless of H. pylori status, were treated with bismuth subsalicylate tablets (524 mg q.i.d.) for 4 wk and metronidazole (250 mg q.i.d.) for the first 2 of the 4 wk. From March 1992 until February 1994, only infected patients were treated in an attempt to obtain equal numbers in each group. H. pylori infection was diagnosed histologically at the index endoscopy and 1 month after completion of therapy. Symptoms were scored on a 0-5 scale for both frequency and severity. RESULTS Of 100 patients screened, 33 were infected with H. pylori (mean age, 42; 10 men, 23 women), and 67 were uninfected (mean age, 38; 16 men, 51 women). Thirty-six uninfected patients were not offered treatment during the latter part of the trial. Of the remaining 31 uninfected patients, 10 dropped out; of the 33 infected patients, 14 dropped out. Twenty-one uninfected patients and 19 H. pylori-infected patients completed treatment; in 13 of 19 patients (68%), H. pylori was eradicated. Symptoms improved in eight of 13 (61%) H. pylori-eradicated patients and in four of six (66%) H. pylori-persistent patients, compared with 14 of 21 (66%) uninfected patients. Long-term follow-up (mean, 34 months) showed similar symptom outcome in the two treatment groups. CONCLUSIONS Thirty-three percent of our non-ulcer dyspepsia patients were infected with H. pylori, a number similar to the percentage of infected age-matched controls in the U.S. Treatment with bismuth subsalicylate and metronidazole resulted in symptomatic improvement in 61-66% of non-ulcer dyspepsia patients regardless of initial or post-treatment H. pylori status. Long-term symptom follow-up in both the control and infected groups gave similar results. H. pylori infection is not related to the symptoms of non-ulcer dyspepsia.

[1]  O vanRensburg,et al.  Helicobacter pylori in peptic ulcer disease. , 2004, Delaware medical journal.

[2]  Fred E. Silverstein,et al.  Helicobacter pylori in peptic ulcer disease. , 1994, NIH consensus statement.

[3]  N. Talley.  A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. , 1994, Gastroenterology.

[4]  K. Mcquaid.  Endoscopy-negative dyspepsia. Hold those forceps! , 1993, Journal of clinical gastroenterology.

[5]  N. Talley.  The role of Helicobacter pylori in nonulcer dyspepsia. A debate--against. , 1993, Gastroenterology clinics of North America.

[6]  R. Corinaldesi,et al.  Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. , 1992, Gastroenterology.

[7]  C. O'Morain,et al.  Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. , 1991, BMJ.

[8]  D. Graham,et al.  Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. , 1991, Gastroenterology.

[9]  N. Talley,et al.  Non‐ulcer dyspepsia: myths and realities , 1991, Alimentary pharmacology & therapeutics.

[10]  J. Y. Kang,et al.  Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. , 1990, Gut.

[11]  M. Blaser,et al.  Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. , 1989, The New England journal of medicine.

[12]  J. Arends,et al.  Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. , 1989, Gut.

[13]  T. Rokkas,et al.  Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. , 1988, Gut.

[14]  N. Talley,et al.  Non-ulcer dyspepsia: potential causes and pathophysiology. , 1988, Annals of internal medicine.

[15]  C. Mcnulty,et al.  Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. , 1986, British medical journal.

[16]  A. Goldner.  Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia: Nyren O, Adami HO, Bates S, et al N Engl J Med 314:339–343 Feb 1986 , 1986 .

[17]  D. Piper,et al.  Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. , 1986, Gastroenterology.

[18]  B. Marshall,et al.  Attempt to fulfil Koch's postulates for pyloric Campylobacter , 1985, The Medical journal of Australia.

[19]  K. Heaton,et al.  Functional Bowel Disorders in Apparently Healthy People , 1980 .

[20]  R. Murphy,et al.  Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s). , 1989, The American journal of gastroenterology.

[21]  M. Korman,et al.  Campylobacter pylori--a role in non-ulcer dyspepsia? , 1989, Scandinavian journal of gastroenterology. Supplement.

[22]  Guido N. J. Tytgat,et al.  Campylobacter pyloridis-associated chronic active antral gastritis. , 1988 .

[23]  B. S. Rappaport.  Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. , 1986, The New England journal of medicine.